Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2003 09:24 ET | Source: Crucell N.V.

Crucell N.V.: Ebola Vaccine Holds Promise for Protection in Humans

LEIDEN, Netherlands, Aug. 7, 2003 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL): In an article published in Nature(1) this week, test results have shown that a new Ebola vaccine gives...
July 14, 2003 02:43 ET | Source: Crucell N.V.

Crucell Announces Second Quarter 2003 Results

LEIDEN, The Netherlands, July 14, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced its financial results for the second quarter of 2003....
June 11, 2003 01:48 ET | Source: Crucell N.V.

Crucell is Developing West Nile Vaccine for Humans

LEIDEN, Netherlands, June 11, 2003 (PRIMEZONE) -- Dutch vaccine and antibody company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it is developing a human West Nile vaccine based...
June 11, 2003 01:41 ET | Source: Crucell N.V.

Crucell and Kimron Veterinary Institute Sign License Agreement for West Nile Veterinary Vaccine

LEIDEN, Netherlands, June 11, 2003 (PRIMEZONE) -- Dutch vaccine and antibody company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today a license agreement with Kimron Veterinary Institute of...
June 03, 2003 02:18 ET | Source: Crucell N.V.

Crucell Expands Relationship with Merck & Co.

LEIDEN, Netherlands, June 3, 2003 (PRIMEZONE) -- Dutch antibody and vaccine company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has expanded the Cooperation Agreement made with...
June 03, 2003 02:10 ET | Source: Crucell N.V.

Crucell and Merck & Co. Sign PER.C6(tm) Licensing Agreement for Therapeutic Protein Production

LEIDEN, Netherlands, June 3, 2003 (PRIMEZONE) -- Dutch vaccine and antibody company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a PER.C6(tm) research license...
April 29, 2003 07:21 ET | Source: Crucell N.V.

Dr. C.E. Wilhelmsson and Mr. S. Lance Nominated to Crucell's Supervisory Board

LEIDEN, The Netherlands, April 29, 2003 (PRIMEZONE) -- Dutch vaccine and antibody company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today the nomination of Dr. C.E. Wilhelmsson and Mr. S....
April 14, 2003 03:01 ET | Source: Crucell N.V.

Crucell Publishes First Quarter 2003 Results

LEIDEN, The Netherlands, April 14, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced its financial results for the first quarter of 2003. -...
February 14, 2003 03:01 ET | Source: Crucell N.V.

Crucell Signs PER.C6 License with Targeted Genetics

LEIDEN, The Netherlands, Feb. 14, 2003 (PRIMEZONE) -- Crucell N.V. (Nasdaq:CRXL) announced today that it has signed a non-exclusive PER.C6(TM) license agreement with Seattle-based Targeted Genetics...
January 27, 2003 02:40 ET | Source: Crucell N.V.

Crucell and Aventis Pasteur Sign License Agreement for Manufacturing Viral Vaccines

LEIDEN, The Netherlands, Jan. 27, 2003 (PRIMEZONE) -- Crucell N.V. (Nasdaq:CRXL) and Aventis Pasteur S.A. (NYSE:AVE) today announced that they have signed a commercial license agreement for...